A wealth of experimental and clinical research supports the premise that inflammation plays an important role in hyperplastic arterial diseases (eg, neointimal hyperplasia and restenosis after coronary intervention and cardiac allograft vasculopathy), in vasculitis, and in the initiation, progression, and complications of atherosclerosis. 1 The pathobiology of arterial disease begins with an inciting injury that activates inflammatory responses from well-characterized cellular and molecular regulatory pathways. Vascular inflammation involves complex heterotypic interactions between endothelial cells, platelets, and inflammatory cells, including neutrophils, monocytes, lymphocytes, and mast cells. 2 Under normal circumstances, the cellular and molecular processes that control vascular injury responses direct repair and vascular healing. In pathological conditions, however, dysregulation of inflammatory responses results in persistent vascular inflammation and adverse arterial remodeling and contributes to the development of clinical vascular diseases.
Clinical Perspective on p 436
Our previous study used a transcriptional profiling strategy to identify novel regulators of vascular inflammation and atherothrombosis by examining platelet mRNA transcripts that are differentially expressed in patients with ST-segment elevation myocardial infarction compared with stable coronary artery disease. 3 Myeloid-related protein-14 (MRP-14, also referred to as S100A9) was one of the strongest candidate proteins that arose from the transcriptional profiling analysis. MRP-14 complexes with MRP-8 (S100A8), another member of the S100 family of calcium-modulated proteins; together, MRP-8 and MRP-14 regulate myeloid cell function by binding to Toll-like receptor-4 (TLR-4) 4 and the receptor for advanced glycation end products 5 and by modulating calcium signaling 6 and cytoskeletal reorganization. 7 In 2 prospective nested case-control studies, 1 in apparently healthy postmenopausal women 3 and the other in patients presenting with acute coronary syndromes, 8 elevated plasma levels of MRP-8/14 predicted the risk of future cardiovascular events independently of traditional cardiovascular risk factors and C-reactive protein. Elevated plasma levels of MRP-8/14 also serve as an early and sensitive marker of myocardial necrosis in the setting of chest pain. 9 Emerging evidence from studies using isolated cells from MRP-14-deficient (MRP-14 Ϫ/Ϫ ) mice strongly suggests that MRP-8 and MRP-14 regulate leukocyte migration. 10 Despite the presence of MRP-8 mRNA transcripts, MRP-14 Ϫ/Ϫ mice lack both MRP-8 and MRP-14 protein as a result of the instability of MRP-8 in the absence of MRP-14. 6, 11 In vitro studies with MRP-14 Ϫ/Ϫ neutrophils show markedly diminished migration through endothelial monolayers and attenuated chemokinesis in a 3-dimensional collagen matrix. 11 An essential role for MRP-14 in leukocyte recruitment in vivo is uncertain because MRP-14 Ϫ/Ϫ mice have normal neutrophil migration during chemical peritonitis 6, 11 and interleukin-8 (IL-8)-induced skin inflammation but have diminished granulocyte recruitment during tissue wound healing 7 and during acute pancreatitis. 12 Recent studies using MRP-14
Ϫ/Ϫ mice have demonstrated that MRP-8 and MRP-14 play a regulatory role in endotoxin-induced phagocyte function. MRP-8 and MRP-14 are endogenous regulators of TLR-4, affecting myeloid MyD88-dependent activation of nuclear factor-B and expression of tumor necrosis factor-␣ (TNF-␣). 4 Although MRP-8 and MRP-14 serve as risk biomarkers and can modulate inflammatory cell function, whether these proteins participate directly in vascular inflammation and in cardiovascular disease remains uncertain. The present study used MRP-14 Ϫ/Ϫ mice to test the hypotheses that MRP-8/14 complexes contribute to neutrophil-dependent and monocyte/ macrophage-dependent vascular inflammatory responses in experimental arterial injury, vasculitis, and atherosclerosis.
Methods

MRP-14
Ϫ/Ϫ mice were generated in the laboratory of Dr Nancy Hogg. 6 For the atherosclerosis experiments, MRP-14 Ϫ/Ϫ mice were crossbred with apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice (Jackson Laboratories, Bar Harbor, Me) to generate compound-mutant mice doubly deficient in MRP-14 and ApoE (MRP-14
). Singlemutant ApoE Ϫ/Ϫ mice were used as controls for the atherogenesis experiments. All mice had a congenic C57BL/6 background and were maintained in animal facilities at Harvard Medical School and Case Western Reserve University School of Medicine. Animal care and procedures were reviewed and approved by the Institutional Animal Care and Use Committees and performed in accordance with the guidelines of the American Association for Accreditation of Laboratory Animal Care and the National Institutes of Health.
Femoral Artery Wire Injury
Bilateral wire injury (0.010 in) of the femoral artery was performed as described previously 13, 14 and as detailed in the Material section of the online-only Data Supplement. Six hours, 7 days, or 28 days after vascular injury, the right and left femoral arteries were excised, embedded in paraffin, and stained with hematoxylin and eosin and Verhoeff tissue elastin stain. A histologist blinded to genotype measured the luminal, intimal, and medial areas of each crosssectional plane using a microscope equipped with a charge-coupled device camera (Zeiss AxioCam MRc5, Oberkochen, Germany) interfaced to a computer running NIH Image. For immunohistochemistry, standard avidin-biotin procedures were used. Percent Mac-3-positive area, percent 7/4 -positive area, and percent glycoprotein IIb-positive area were defined as the fraction of immunopositive staining to total area measured. Methods for human aortic smooth muscle cell (SMC) culture, mouse aortic SMC culture, and SMC MTT proliferation assays are detailed in the Material section of the online-only Data Supplement.
Vasculitis Experiments: Local Shwartzman Reaction
Induction of vasculitis (the local Shwartzman reaction) was performed as described previously 15 and as detailed in Material section of the online-only Data Supplement. Briefly, 200 g lipopolysaccharide was injected subcutaneously into the skin, and 24 hours after the lipopolysaccharide injection, 300 ng TNF-␣ was injected into the same site to enhance vasculitic lesion formation. On day 4, mice were euthanized and skin tissue was harvested for semiquantitative macroscopic grading of skin lesions and histological analysis. For immunohistochemistry, standard avidin-biotin procedures were used. The extravascular red blood cell signal in hematoxylin and eosin-stained sections indicated hemorrhage, whereas the red signal inside arteries and veins was excluded. Percent hemorrhage area was defined as the fraction of extravascular red signal area to total area measured. Neutrophil accumulation was assessed by determining monoclonal antibody 7/4 -positive area.
Atherosclerosis Experiments: ApoE Model of High-Fat Diet-Induced Atherosclerosis
To induce atherosclerosis, 8-week-old male ApoE Ϫ/Ϫ (nϭ22) or doubly deficient ApoE Ϫ/Ϫ MRP-14 Ϫ/Ϫ (nϭ20) mice consumed a high-fat diet (Clinton/Cybulsky Rodent Diet D12108 with 1.25% cholesterol, Research Diets, New Brunswick, NJ) for 20 weeks. As detailed in the Material section of the online-only Data Supplement, Sudan IV staining was used to quantify atherosclerotic lesion area. Macrophage (Mac-3-positive cells) accumulation in atherosclerotic lesions was assessed in the descending aorta and aortic arch (lesser curvature), and percent macrophage area was calculated by determining the Mac-3-positive area using computer-assisted imaging analysis. Methods for in vitro cytokine production and transwell assays are detailed in the Material section of the online-only Data Supplement.
Statistical Analysis
Unless otherwise noted, data are presented as the meanϮSD, and statistical analysis was done with a Student t test. Values of PϽ0.05 were considered significant. Correlation analyses for the atherosclerosis experiments (open versus closed lesion area, macrophage staining of the descending aorta versus aortic arch) were done using the correlation function in Microsoft Excel.
Results
MRP-8/14 Complexes Regulate Neutrophil and Monocyte Recruitment and Neointimal Thickening After Femoral Artery Injury
To determine whether MRP-8/14 complexes influence arterial injury responses and neointimal formation, we performed femoral artery wire injury in wild-type (WT) and MRP-14 Ϫ/Ϫ mice. Wire injury causes endothelial denudation, medial injury, and platelet and fibrin deposition and yields prominent inflammation of all arterial layers. 13 Inflammation after wire injury involves both neutrophils and monocytes. We and others have demonstrated the critical participation of inflammatory cell recruitment in neointimal formation in wire-injured mouse arteries. 13, 14 Wire injury resulted in a significant increase in MRP-8 and MRP-14 expression in the vessel wall (no injury, Figure 1A and 1B; 7 days after injury, Figure 1C and 1D). As expected, neither MRP-8 nor MRP-14 expression was detected in the injured arteries of MRP-14 Ϫ/Ϫ mice ( Figure 1E and 1F). We next examined leukocyte recruitment 7 days after wire injury, the time corresponding to peak inflammatory cell infiltration in this model. 13 Accumulation of leukocytes in the developing neointima (CD45 staining) was reduced significantly by 45% (percent CD45-positive area: WT, 13.1Ϯ7.2%; MRP-14 Ϫ/Ϫ , 7.2Ϯ5.4%; Pϭ0.028) in MRP-14 Ϫ/Ϫ compared with WT mice ( Figure 2A and 2B and Table 1 ). We expanded the CD45 analysis by immunostaining for the macrophage-specific marker Mac-3 and the neutrophil-specific marker 7/4 ( Figure  2C through 2F and Ϫ/Ϫ mice after wire injury. A and B, CD45 immunostaining 7 days after injury. C and D, Mac-3 immunostaining 7 days after injury. E and F, 7/4 Immunostaining 7 days after injury. G and H, BrdU immunostaining 7 days after injury. I and J, Verhoeff elastin stain 28 days after injury. Arrows delineate the internal elastic lamina (original magnification ϫ10).
gether, these observations indicate that MRP-8/14 complexes modulate neutrophil-and monocyte-dependent vascular inflammation and neointimal thickening after experimental mechanical arterial injury and suggest that MRP-8/14 complexes modulate cellular proliferation that is stimulated by platelets and/or leukocytes in this setting. Importantly, differences in neointimal formation between WT and MRP-14 Ϫ/Ϫ mice did not appear to be related to altered platelet deposition; WT and MRP-14 Ϫ/Ϫ mice showed similar staining for the platelet marker glycoprotein IIb 6 hours after injury (Pϭ0.96) ( Figure I of the online-only Data Supplement). In addition, altered hemodynamics did not appear to influence inflammatory responses in the MRP-14 Ϫ/Ϫ mice because WT and MRP-14 Ϫ/Ϫ mice had similar systolic, diastolic, and mean arterial pressures in the awake and conscious states as measured by the tail cuff method (Table 2) .
Vascular SMCs are known to express MRP-14. 16 To examine the role of MRP-8/14 in SMC proliferation relevant to vascular injury and restenosis, we isolated SMCs from the aortas of WT and MRP-14 Ϫ/Ϫ mice and examined basal and platelet-derived growth factor-stimulated proliferation in vitro by MTT assay (Figure 3 ). Aortic SMCs from MRP-14 Ϫ/Ϫ mice had significantly reduced basal and platelet-derived growth factor-stimulated proliferation in vitro (PϽ0.0001 by ANOVA). In contrast, the addition of purified human MRP-8 and MRP-14 had no effect on the proliferation of human aortic SMCs ( Figure II of the online-only Data Supplement). Taken together, these data likely indicate a role for intracellular MRP-8/14 action (calcium transients, cytoskeletal reorganization, arachidonic acid metabolism) in the regulation of SMC proliferation.
MRP-8/14 Complexes Regulate Neutrophil-Dependent Thrombohemorrhagic Vasculopathy
Next, we examined the role of MRP-8/14 complexes in cytokine-and neutrophil-dependent inflammation. MRP-14 regulates neutrophil functions in vitro, and neutrophil-derived cytotoxic products play an important role in cytokine-induced inflammation of the vessel wall. The local Shwartzman-like reaction (LSR), induced by successive lipopolysaccharide and cytokine injections into the skin, produces a thrombohemorrhagic vasculitis. 15, 17 Consistent with prior reports, 4 flow cytometry demonstrated equivalent expression of the lipopolysaccharide receptor TLR-4 on bone marrow-derived and thioglycolate-elicited peritoneal macrophages harvested from WT and MRP-14 mice (data not shown). The LSR depends on neutrophils and their interaction with activated platelets and endothelial cells. 15, 17, 18 Neutrophil-derived microparticles promote the accumulation of fibrin, generation of occlusive thrombi, and eventual hemorrhage from inflamed blood vessels. 17 The LSR produces hemorrhage in the intact skin 24 hours after TNF-␣ injection. MRP-14 Ϫ/Ϫ mice subjected to LSR exhibited a significant reduction in the development of hemorrhagic lesions (nϭ13 mice per group; Figure 4A 
MRP-8/14 Complexes Modulate Monocyte/Macrophage-Dependent Atherosclerotic Lesion Formation
Mice with experimental atherosclerosis, a process driven by monocyte recruitment and function, were used in examinations of the role of MRP-8/14 in monocyte/macrophagedependent vascular inflammation. 19 -21 Because we have shown that plasma levels of MRP-8/14 predict cardiovascular events related to atherosclerotic plaque rupture and thrombosis, 3, 8 we examined whether plasma levels of MRP-14 increase during the development of atherosclerosis in mice. WT and atherosclerosis-prone ApoE Ϫ/Ϫ mice were started on an atherogenic diet at 8 weeks of age, and 12 weeks later, plasma levels of MRP-14 were assessed by immunoblotting. We generated compound-mutant mice deficient in both ApoE and MRP- 14 Figure 6A and 6B). 
Human Carotid Atheroma Contain MRP-8/14
To begin to investigate the relevance of MRP-8/14 in human disease, we examined the expression of MRP-8, MRP-14, and MRP-8/14 in normal human carotid arteries and in carotid atheroma. Carotid atheroma, but not normal arteries (nϭ5), contain abundant MRP-8, MRP-14, and heterodimeric MRP-8/14 (identified through the use of the heterodimer complexspecific antibody 27E10) ( Figure 8A through 8L) . Analysis of adjacent tissue sections demonstrated that MRP-8, MRP-14, and MRP-8/14 staining is largely associated with lesional CD68-positive macrophages (ϫ40 serial sections in Figure  8B , 8E, 8H, and 8K). MRP-8, MRP-14, and MRP-8/14 were expressed robustly in all types of atherosclerotic lesions, including fatty streaks (nϭ6 samples), SMC-rich atheroma with stable features (nϭ6), and inflammatory cell-rich atheroma with thin caps and features of plaque instability (nϭ4; Figure V of the online-only Data Supplement).
Discussion
This study shows that deficiency of MRP-8 and MRP-14 reduces neutrophil-and monocyte-dependent vascular inflammation and attenuates the severity of diverse vascular injury responses in vivo. These observations establish that MRP-8 and MRP-14 participate importantly in the biological response to vascular injury.
Analyses of mice that lack MRP-8 and MRP-14 have provided important insights into the function of these proteins. Although the homozygous deletion of MRP-8 results in embryonic lethality, 22 Recent observations in MRP-14 Ϫ/Ϫ mice indicate that MRP-8/14 is essential for lipopolysaccharide-induced septic shock, 4 neutrophil-dependent Staphylococcus aureus killing, 23 and neutrophil infiltration in acute pancreatitis 12 ; however, a direct role for MRP-8 and MRP-14 in vascular inflammation and in the pathophysiology of vascular disease was heretofore unrecognized. Prior studies examining MRP-8/14 in vascular inflammation found high MRP-8/14 levels in neutrophils in large-vessel vasculitis 24 and in macrophages and foam cells in human 25 and mouse 26 atherosclerotic lesions. The 3 experimental forms of vascular inflammation used in our study depend variably on neutrophils (vasculitis), monocyte/ macrophages (atherosclerosis), or their combination (arterial wire injury). This study shows that MRP-8 and MRP-14 promote the recruitment of inflammatory cells and tissue injury, as assessed by neointimal formation (wire injury), hemorrhage area (vasculitis), and atherosclerotic plaque area (atherosclerosis).
Our data strongly suggest that MRP-8/14 influences vascular inflammation and the development of vascular disease through multiple mechanisms that include regulation of vascular SMC proliferation, regulation of MCP-1-stimulated monocyte migration, and regulation of the production of key cytokines (TNF-␣, MCP-1, IL-1␤, and IL-12). A particularly notable feature of the phenotype of MRP-14 Ϫ/Ϫ mice in all 3 disease models (wire injury, vasculitis, atherosclerosis) is the significant reduction in the accumulation of neutrophils and macrophages in the inflamed tissue. This phenotype of reduced leukocyte accumulation is supported by several studies demonstrating MRP-8/14 regulation of myeloid adhesion and transmigration across the blood vessel wall. 11, [27] [28] [29] [30] In vitro studies with MRP-14 Ϫ/Ϫ neutrophils show markedly diminished migration through endothelial monolayers and attenuated chemokinesis in collagen gels, 11 and although MRP-14 Ϫ/Ϫ mice have normal neutrophil migration during chemical peritonitis, MRP-14 promotes the recruitment of neutrophils into granulation tissue during wound healing in vivo, 7 into pancreatic tissue during acute pancreatitis, 12 and into the skin during IL-8 -stimulated inflammation. 6, 11 Recently, MRP-8/14 was linked to leukocyte activation in lethal endotoxin-mediated shock, but that report did not identify the in vivo source of MRP-8/14 and did not study the effects of MRP-8/14 deficiency on leukocyte recruitment during sepsis. 4 It is possible that MRP-8/14 regulates leukocyte adhesion during vascular inflammation through control of the expression and function of the leukocyte integrin adhesion molecule Mac-1 (CD11b/CD18, ␣M␤2). 11,30,31 MRP-14 Ϫ/Ϫ neutrophils have reduced Mac-1 expression at baseline and in response to cell activation, 11 and MRP-14 binds to a distinct neutrophil receptor, resulting in inside-out signaling events that promote Mac-1 activation and increase cell adhesiveness. 31 MRP-8/14 induces Mac-1 expression on monocytes and enhances endothelial transmigration via intracellular adhesion molecule-1-dependent pathways. 32 We have shown previously that Mac-1 directs leukocyte recruitment and is critical for the biological response to vascular injury and neointimal formation. 14, 33 These studies linking MRP-8/14 function to leukocyte adhesion and transmigration are consistent with our data that MRP-14 deficiency reduces MCP-1-stimulated monocyte transmigration. It is also possible that extracellular MRP-8/14 regulates leukocyte recruitment during the development of vascular disease by functioning as a chemoattractant or by binding to cell receptors that activate leukocytes. MRP-8/14 interacts with the receptor for advanced glycation end products 5 and TLR-4 4 receptors, which both modulate vascular inflammation and have important roles in the pathobiology of atherosclerosis. 34, 35 Other putative receptors for MRP-8/14 on target cells include CD36, 36 special carboxylated N-glycans, 37 and heparinlike glycoaminoglycans. 38 In the vascular injury model, MRP-8/14 appears to control the inflammatory response at several levels, including regulation of macrophage and neutrophil accumulation and regulation of vascular SMC proliferation. Our finding that MRP-14 deficiency attenuates mouse vascular SMC proliferation is consistent with a recent report linking MRP-8/14 function to bacteria-induced proliferative responses in human vascular SMCs. 16 Despite equivalent TLR-4 receptor expression in WT and MRP-14 Ϫ/Ϫ mice, mechanistic interpretation of the LSR response in MRP-14 Ϫ/Ϫ mice is complicated by the fact that lipopolysaccharide is used to stimulate the LSR. Because MRP-8/14 itself modulates lipopolysaccharide signaling via TLR-4, 4 attenuated LSR response could be secondary to dampened TLR-4 signaling in MRP-14 Ϫ/Ϫ mice. However, the LSR requires subcutaneous injection of TNF-␣ 24 hours after lipopolysaccharide, making it unlikely that reduced TLR-4 signaling (ie, production of TNF-␣) could solely account for the effect in MRP-14 Ϫ/Ϫ mice. Rather, we believe that a combination of the intracellular actions of MRP-14 (regulation of calcium-dependent signaling, 5,6 integration of mitogen-activated protein kinase activity, 7 regulation of microtubule reorganization, 7 regulation of arachidonic acid metabolism, and trafficking 27, 39 ) and extracellular actions of MRP-14 (receptor-dependent signaling through TLR-4, 4 receptor for advanced glycation end products, 5 CD36, 36 and possibly other receptors 38 ) accounts for the attenuated thrombohemorrhagic vasculitic response in vivo. Furthermore, reduced leukocyte Mac-1 expression and ligand binding are well documented in MRP-14 Ϫ/Ϫ mice, and reduced MRP-8/ 14 -dependent Mac-1 adhesion/activation 11, 30, 31 could account for attenuation of the LSR response because this model is dependent on Mac-1-mediated neutrophil function. 15 With regard to the role of MRP-8/14 in atherosclerosis, recent studies have demonstrated that free cholesterol accumulation in macrophage membranes activates TLRs and p38 mitogen-activated protein kinase and induces production and secretion of MRP-8. 40 It is possible that hyperlipidemiainduced macrophage expression of MRP-8/14 could promote leukocyte recruitment and atherogenic cytokine production, a hypothesis that is supported by our demonstration of MRP-8/14 expression in fatty streaks and advanced atheroma. Furthermore, the demonstration of reduced cytokine production by MRP-14 Ϫ/Ϫ macrophages and the demonstration of reduced atherosclerotic lesion size and plaque macrophage accumulation in ApoE Ϫ/Ϫ MRP-14 Ϫ/Ϫ mice suggest a regulatory role for MRP-8/14 in leukocyte recruitment and cytokine production during atherogenesis. A regulatory role for MRP-8/14 in atherogenesis is further supported by the recent discovery that MRP-8/14 expression levels are increased in microarray analysis of gene expression in normal compared with atherosclerotic human arteries in which statistical analysis of gene expression patterns suggested a role for MRP-8/14 in the development of atherosclerotic vascular disease. 41 
Limitations
The present study does not clarify whether neutrophil-, monocyte-, or platelet-derived MRP-8 and/or MRP-14 account for the action of these proteins in the pathophysiology of inflammatory vascular disease. Although platelet deposition after wire injury was similar in WT and MRP-14 Ϫ/Ϫ mice, we have not excluded a regulatory role for MRP-14 in platelet functions that influence vascular injury responses. Tissuespecific knockdown of MRP-14 is required to establish the relative contributions of MRP-8 and MRP-14 action in specific hematopoietic cell types, and investigations into the role of MRP-14 in platelet function will be the focus of future research. The relevance of these observations to human disease awaits expanded studies with human tissues, although the present observations document high levels of MRP-8/14 in human carotid artery atheroma (Figure 8 and Figure V of the online-only Data Supplement), and elevated plasma levels of MRP-8/14 are associated with adverse cardiovascular outcomes in patients. 3, 8 
Conclusions
This study demonstrates that MRP-8/14 broadly regulates vascular inflammation and contributes to biological responses to various vascular insults by controlling neutrophil and macrophage accumulation, macrophage cytokine production,
